Figure 3From: Open-label, randomized, non-inferiority clinical trial of artesunate-amodiaquine versus artemether-lumefantrine fixed-dose combinations in children and adults with uncomplicated falciparum malaria in Côte d'IvoireProportion of patients with parasites during follow up. Note: The proportion of participants who were aparasitaemic was similar between the two treatment arms: 98.9% and 99.5% (P =0.49) for those receiving AS-AQ or AL, respectively, on day 2. On day 3 these rates were 100% in the two arms. Abbreviations: AL, artemether-lumefantrine; AS-AQ, artesunate + amodiaquine.Back to article page